Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Rachel Jimenez, M.D.

Concepts (249)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms352023208241.990 Why?
Radiation Oncology1120235551.910 Why?
Breast Implantation620222181.230 Why?
Mammaplasty5202212041.210 Why?
Radiotherapy Planning, Computer-Assisted11202216241.040 Why?
Radiotherapy, Intensity-Modulated220218060.960 Why?
Breast Implants320223870.930 Why?
Mastectomy11202217930.830 Why?
Radiotherapy Dosage10202228790.780 Why?
Thoracic Wall320182030.690 Why?
Breast Neoplasms, Male120212100.680 Why?
Tattooing12019580.660 Why?
Sarcopenia120233680.630 Why?
Radiation Injuries3202211800.630 Why?
Curriculum9202236050.600 Why?
Mammary Neoplasms, Animal120181370.590 Why?
Medical Oncology4202222670.560 Why?
Mastectomy, Segmental320219560.550 Why?
Benchmarking1202210420.530 Why?
Organs at Risk420223460.530 Why?
Mediastinal Neoplasms120184230.510 Why?
Breast4202119700.480 Why?
Women's Health1202220340.430 Why?
Protons4202211270.430 Why?
Neuroectodermal Tumors, Primitive120131400.420 Why?
Pituitary Neoplasms1202113450.420 Why?
Neoplasms, Second Primary1202010620.420 Why?
Supratentorial Neoplasms120131600.410 Why?
Heart3202244640.400 Why?
Ventricular Dysfunction, Left1202220730.390 Why?
Radiobiology22020850.340 Why?
Lymphoma1201818770.330 Why?
Internship and Residency4202357910.320 Why?
Chemotherapy, Adjuvant4202334800.320 Why?
Cerebellar Neoplasms120135870.310 Why?
Lymph Nodes1201934760.310 Why?
Medulloblastoma120136830.310 Why?
Photons420195880.300 Why?
Female4320233801930.280 Why?
Humans6420237443660.270 Why?
Clinical Clerkship320155320.250 Why?
Neoplasms62023216960.250 Why?
Cultural Diversity220233590.240 Why?
Radiotherapy, Conformal320185480.240 Why?
Patient Participation1201314570.230 Why?
Neoplasm Recurrence, Local6202392400.230 Why?
Seroma12022710.210 Why?
Hypertension1202284790.210 Why?
Program Evaluation4202024880.210 Why?
Family Leave12021180.200 Why?
Supreme Court Decisions120221280.190 Why?
Education, Nursing12021820.190 Why?
Relative Biological Effectiveness220213230.180 Why?
Sick Leave120211100.180 Why?
Clinical Trials as Topic3202379140.180 Why?
Accreditation120234520.180 Why?
Students, Medical4202118620.180 Why?
Physics12019870.170 Why?
Cranial Irradiation220134010.170 Why?
Thorax120225470.170 Why?
Retrospective Studies132023774600.170 Why?
Rib Fractures120201310.160 Why?
Troponin120225240.160 Why?
Education, Medical, Graduate2202322910.160 Why?
Canada2202220650.160 Why?
Craniopharyngioma120212810.160 Why?
Necrosis1202216430.160 Why?
Moyamoya Disease120212380.160 Why?
Nausea120216740.160 Why?
Lymphatic Metastasis2201829240.150 Why?
Vomiting120216370.150 Why?
Safety1202211860.150 Why?
Hematoma120227580.150 Why?
Policy120215080.150 Why?
Radiation-Sensitizing Agents120193580.140 Why?
Radiation Tolerance120194860.140 Why?
Congresses as Topic120207640.140 Why?
Patient Care Planning120219210.130 Why?
Physician-Patient Relations3202132290.130 Why?
Treatment Outcome112023631070.130 Why?
Aged1420231632880.130 Why?
Patient Positioning120183240.130 Why?
Asymptomatic Diseases120185510.130 Why?
Tumor Burden1202119150.130 Why?
Antineoplastic Agents, Hormonal1202315240.130 Why?
Cisplatin1202116620.120 Why?
Postoperative Care2201814870.120 Why?
Postoperative Complications32022152970.120 Why?
Pulmonary Fibrosis120185300.120 Why?
Vision Disorders1202110580.120 Why?
Fatigue1202115310.110 Why?
Disease-Free Survival2202168960.110 Why?
Propensity Score1202017810.110 Why?
Middle Aged1820232133900.110 Why?
Small Molecule Libraries120197200.110 Why?
Headache1202112260.110 Why?
Quality of Life52022128020.110 Why?
Ventricular Function, Left2202236660.100 Why?
Health Services Needs and Demand1202014100.100 Why?
Stroke Volume2202250060.100 Why?
Needs Assessment1201811470.100 Why?
Acculturation120131820.100 Why?
Surgical Flaps1202016400.100 Why?
Adult1620232140520.100 Why?
Proto-Oncogene Proteins p21(ras)1201916920.100 Why?
Terminal Care2201316940.100 Why?
Schizophrenia, Paranoid120111040.100 Why?
Endocrine System Diseases120132480.100 Why?
Sleep Initiation and Maintenance Disorders1202010040.100 Why?
Attitude to Death120133820.090 Why?
Terminally Ill120132380.090 Why?
Ambulatory Care1202127080.090 Why?
Bone Density Conservation Agents120177720.090 Why?
Massachusetts2202186620.090 Why?
Peptide Fragments1202250960.090 Why?
Echocardiography1202250990.090 Why?
Pectoralis Muscles22020820.090 Why?
Prospective Studies62022532900.090 Why?
Feedback320217950.090 Why?
Radiotherapy, Adjuvant3202017710.090 Why?
Antineoplastic Combined Chemotherapy Protocols32020115250.080 Why?
Interviews as Topic2201325390.080 Why?
Feasibility Studies1201950770.080 Why?
United States72022698720.080 Why?
Patient Preference220138890.080 Why?
Receptor, erbB-21201824170.080 Why?
Young Adult52023564290.080 Why?
Male1220233501150.080 Why?
Career Choice120147440.070 Why?
Kaplan-Meier Estimate1201865390.070 Why?
Hearing Loss, Sensorineural120137700.070 Why?
Radiology1202120990.070 Why?
Genomics1202357170.070 Why?
Follow-Up Studies42022390520.070 Why?
Body Height1201315780.070 Why?
Education, Medical, Undergraduate1201510080.070 Why?
Cultural Competency120092890.070 Why?
Hospice Care120136720.070 Why?
Survival Rate22018127880.070 Why?
Infant22021351340.070 Why?
Cross-Sectional Studies22023250390.060 Why?
Bone Neoplasms1201725300.060 Why?
Child, Preschool22021410050.060 Why?
Neoplasm Staging42021110310.060 Why?
Radiosurgery1201413290.060 Why?
Mass Screening1202052530.060 Why?
Neoadjuvant Therapy3202027270.060 Why?
Cause of Death1201335820.050 Why?
Lung2201898570.050 Why?
Coronavirus Infections1202031350.050 Why?
Pneumonia, Viral1202032420.050 Why?
Aged, 80 and over42023577760.050 Why?
Brain Neoplasms2201488610.050 Why?
Consensus2202129600.050 Why?
Linear Energy Transfer120211540.050 Why?
Governing Board12019530.040 Why?
Maximum Tolerated Dose120218920.040 Why?
Administrative Personnel120191870.040 Why?
Program Development2201513160.040 Why?
Logistic Models12013134090.040 Why?
Surgical Mesh120202760.040 Why?
Pandemics3202283850.040 Why?
Radiology, Interventional120214600.040 Why?
Costs and Cost Analysis1202216800.040 Why?
Longitudinal Studies12013139910.040 Why?
Cost Allocation12016510.030 Why?
Lung Neoplasms22019131040.030 Why?
Drug Screening Assays, Antitumor120197300.030 Why?
Certification120194230.030 Why?
Single-Blind Method1202015900.030 Why?
Cost-Benefit Analysis2202153880.030 Why?
Fluorouracil1202016190.030 Why?
Educational Measurement2201512100.030 Why?
Phenylurea Compounds120195280.030 Why?
Models, Econometric120162180.030 Why?
Gene Expression Regulation, Leukemic120196510.030 Why?
Organ Specificity1202020080.030 Why?
Monte Carlo Method1202012540.030 Why?
Prognosis32023290600.030 Why?
Device Removal120206560.030 Why?
DNA Breaks, Double-Stranded120195940.030 Why?
Clinical Trials, Phase III as Topic120178410.030 Why?
Chicago120142400.030 Why?
Child12021777090.030 Why?
Diphosphonates120176230.030 Why?
Pyrazines1201912300.030 Why?
Adolescent12021857790.030 Why?
Carcinoma, Intraductal, Noninfiltrating120209480.030 Why?
Markov Chains120169690.030 Why?
Randomized Controlled Trials as Topic2201999550.030 Why?
Advance Directives120132460.030 Why?
Fear1202014400.020 Why?
Imidazoles1201712060.020 Why?
Social Support1202021180.020 Why?
Catheterization1201614700.020 Why?
Tomography, X-Ray Computed32018201300.020 Why?
Clinical Competence2201846870.020 Why?
Reoperation1202042010.020 Why?
Age Factors22017183730.020 Why?
Quality-Adjusted Life Years1201616830.020 Why?
Retreatment120116100.020 Why?
Life Expectancy1201611840.020 Why?
Disease Management1202024600.020 Why?
Delusions120113000.020 Why?
Hospitals, Teaching1201411800.020 Why?
Combined Modality Therapy1202186420.020 Why?
Cell Survival1201958820.020 Why?
Proportional Hazards Models12023123560.020 Why?
Communication1202237500.020 Why?
Patient Selection1202042160.020 Why?
Radiometry120138000.020 Why?
Societies, Medical1201937430.020 Why?
Hospitals, General120117490.020 Why?
Biopsy1201967550.020 Why?
Decision Support Systems, Clinical1201611640.020 Why?
Small Cell Lung Carcinoma120113880.020 Why?
Multivariate Analysis12020122440.020 Why?
Animals120181687680.020 Why?
Faculty120093870.020 Why?
Steroids120119300.020 Why?
Problem-Based Learning120093610.020 Why?
Internet1201830560.020 Why?
Recurrence1201783400.020 Why?
Remission Induction1201123850.020 Why?
Health Care Surveys1201324530.020 Why?
Risk Factors32020722960.020 Why?
Pilot Projects1201883190.020 Why?
Heart Ventricles1201738170.020 Why?
Academic Medical Centers1201527600.020 Why?
HIV Infections12011167150.020 Why?
Survival Analysis12017102520.020 Why?
Dexamethasone1201119510.010 Why?
Mutation22019297860.010 Why?
Time Factors22018400750.010 Why?
Cell Proliferation12019104830.010 Why?
Adaptation, Psychological1201325750.010 Why?
Cell Line, Tumor12019166900.010 Why?
Registries1201780910.010 Why?
Caregivers1201320950.010 Why?
Coronary Disease1201660770.010 Why?
Boston1201493120.010 Why?
Sensitivity and Specificity12016147230.010 Why?
Radiography1201170230.010 Why?
Palliative Care1201134930.010 Why?
Reproducibility of Results12013199050.010 Why?
Disease Progression12011132860.010 Why?
Carcinoma, Non-Small-Cell Lung1201152230.010 Why?
Colorectal Neoplasms1201167730.010 Why?
Magnetic Resonance Imaging12014354250.000 Why?
Jimenez's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (249)
Explore
_
Co-Authors (98)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.